Table 1.
Clinical characteristics of patients with SLE
| Categories | SLE (n = 44) |
|---|---|
| Females, n (%) | 40 (89.0) |
| Age, mean (S.D.), years | 39.0 ± 15.0 |
| SLEDAI score, mean (S.D.) | 9.2 ± 6.1 |
| ds-DNA (+, > 100 IU/mL), n (%) (43 patients) | 21 (48.8) |
| Anti-ENA (42 patients) | |
| Anti-Sm, n (%) | 11 (26.2) |
| Anti-Ro52, n (%) | 21 (50.0) |
| Anti-nRNP/Sm, n (%) | 15 (35.7) |
| Anti-rRNP, n (%) | 13 (31.0) |
| Anti-nucleosome, n (%) | 17 (40.5) |
| Anti-SSA, n (%) | 29 (69.0) |
| Anti-SSB, n (%) | 2 (4.8) |
| Decreased C3, n (%) | 31 (70.5) |
| Decreased C4, n (%) | 29 (65.9) |
| Increased IgG, n (%) | 21 (47.7) |
| Elevated ESR, n (%) | 27 (61.4) |
| Clinical features | |
| Fever, n (%) | 4 (9.1) |
| Cutaneous manifestations, n (%) | 20 (45.5) |
| Oral ulcer, n (%) | 3 (6.8) |
| Alopecia, n (%) | 8 (18.2) |
| Arthritis, n (%) | 16 (36.4) |
| Neuropathic lupus, n (%) | 3 (6.8) |
| Effusion, n (%) | 8 (18.2) |
| 24 hours proteinuria, n (%) | 10 (22.7) |
| Hematuresis, n (%) | 6 (13.6) |
| Pyuria, n (%) | 5 (11.4) |
| Leucopenia | 13 (29.5) |
| Erythrocytopenia | 21 (47.7) |
| Thrombocytopenia | 9 (20.5) |
| Anemia | 23 (52.3) |
Anti-dsDNA, anti double-stranded DNA; Anti-ENA, anti extractable nuclear antigen; C3, complement 3; C4, complement 4; ESR, erythrocyte sedimentation rate; IgG, immunoglobulin G; RNP, ribonucleoprotein; rRNP, ribosomal RNP; SLE, Systemic lupus erythematosus; SLEDAI, SLE disease activity index; WBC, white blood cell.